Sun Pharma successfully removed an injunction in the US on the launch of its Leqselvi for alopecia areata, a common form of hair loss, that was sought by rival Incyte. The decision in the US Court ...

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE ...

This week, we take a closer look at two precedential cases concerning pharmaceutical patent protections as applied to drugs in development.

Includes Detailed Profiles of Industry Giants Eli Lilly & Company, Pfizer, Sun Pharmaceutical Industries, Arcutis Biotherapeutics, Bristol-Myers Squibb, AbbVie, Regeneron Pharmaceuticals, and Aclaris ...

Sun Pharmaceutical Industries Inc. (Sun Pharma), the fourth largest specialty generic pharmaceutical company globally, is offering a summer internship program in 2025 for students to gain ...

He sees a significant hit on stock prices of Indian pharma exporters today. Sun Pharmaceutical Industries led the fall as its share price crashed more than 5% during the morning trade on Monday.

Nifty Pharma share price today, May 12: The share price of Sun Pharma has fallen 7.5% in the last five trading sessions. (Image: Pixabay) It’s a strong Monday across most of Dalal Street ...

Sun Pharma is the worst-hit, plunging over 5 per cent in early trade. The company has significant exposure to the US generics and dermatology markets through its subsidiary Taro Pharma, making it ...

Sun Pharmaceutical Industries Ltd. 524715 shares inched up 0.84% to 1,700.35 Indian rupees Tuesday, on what proved to be an all-around rough trading session for the stock market, with the BSE ...